Stay updated on Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Sign up to get notified when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.

Latest updates to the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe page footer revision was updated from v3.5.2 to v3.5.3, indicating a platform release/version change rather than a modification to the underlying clinical trial information.SummaryDifference0.1%

- Check28 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check57 days agoChange DetectedRevision: v3.5.0 added and Revision: v3.4.3 removed.SummaryDifference0.1%

- Check64 days agoChange DetectedAdded Revision: v3.4.3; Deleted Revision: v3.4.2. This seems to be a system update rather than a substantive change to study details.SummaryDifference0.1%

- Check93 days agoChange DetectedRevision updated from v3.4.1 to v3.4.2; no visible edits to core study data, eligibility criteria, outcomes, or locations. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check100 days agoChange DetectedRevision: v3.4.1 is listed, replacing v3.4.0, with no substantive study content changed; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Gemcitabine Cisplatin Nivolumab in Bladder Sparing Clinical Trial page.